Appointment of VP Global Sales
09 October 2013
Instem plc
("Instem", the "Company" or the "Group")
Appointment of VP Global Sales
Instem plc (AIM: INS.L), a leading provider of IT applications to the global early development healthcare market, announces that it has appointed Edward Lorenti as its new Vice President of Global Sales.
Based in the US, Mr Lorenti has responsibility for global sales, bringing together the current teams of sales professionals for each business unit and the strong existing account relationships. His focus will be on growing market share in existing segments and opening up new areas with the Company’s broadening product set. The new position will strengthen Instem’s ability to address continued global demand for integrated solutions, as the Company continues its organic and acquisitive expansion within the early development market.
Mr Lorenti has over 24 years’ sales and business development experience within organisations providing enterprise software products and solutions in the life sciences industry. His extensive sales and sales management experience has been demonstrated with both mature and emerging products introduced both organically and through acquisitions.
Mr. Lorenti joins Instem from the technology solutions division of Accenture, which he joined in 2012 through its acquisition of Octagon Research Solutions where he was responsible for the enterprise content management and submission software platform serving pharmaceutical and biotechnology clients worldwide.
Phil Reason, CEO of Instem plc, commented: “We are delighted that Ed has joined Instem in this strategically important role at this stage of the Company’s evolution. The appointment of a senior sales manager with vast international experience in the sector is key to aligning our global sales organisation across Instem’s four distinct product ranges. We look forward to working with Ed in delivering further business success, as we meet the increasing needs of our clients to purchase integrated software solutions.”
For further information, please contact:
| Instem plc | www.instem.com |
| Phil Reason, CEO | +44 (0) 1785 825600 |
| Nigel Goldsmith, CFO | |
| N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
| Richard Lindley | |
| Nick Owen | |
| James White | |
| Wallbrook Financial PR | Tel: +44 (0) 20 7933 8000 |
| Paul Cornelius | or instem@walbrookpr.com |
| Sam Allen | |
| Helen Cresswell | |
| Paul Whittington |
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidlyexpanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 450 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
To learn more about Instem solutions and its mission, please visit instem.com.